GO
Loading...

BMY Buys Inhibitex for $2.5B

Monday, 9 Jan 2012 | 12:35 PM ET

Idenix is up on Inhibitex deal. The traders take a look at Bristol Meyers acquisition of Inhibitex for $2.6 billion.